Literature DB >> 22747430

Revisiting the role of glycosylation in the structure of human IgG Fc.

M Jack Borrok1, Sang Taek Jung, Tae Hyun Kang, Arthur F Monzingo, George Georgiou.   

Abstract

Binding of the Fc domain of Immunoglobulin G (IgG) to Fcγ receptors on leukocytes can initiate a series of signaling events resulting in antibody-dependent cell-mediated cytotoxicity (ADCC) and other important immune responses. Fc domains lacking glycosylation at N297 have greatly diminished Fcγ receptor binding and lack the ability to initiate a robust ADCC response. Earlier structural studies of Fc domains with either full length or truncated N297 glycans led to the proposal that these glycans can stabilize an "open" Fc conformation recognized by Fcγ receptors. We determined the structure of an E. coli expressed, aglycosylated human Fc domain at 3.1 Å resolution and observed significant disorder in the C'E loop, a region critical for Fcγ receptor binding, as well as a decrease in distance between the C(H)2 domains relative to glycosylated Fc structures. However, comparison of the aglycosylated human Fc structure with enzymatically deglycosylated Fc structures revealed large differences in the relative orientations and distances between C(H)2 domains. To provide a better appreciation of the physiologically relevant conformation of the Fc domain in solution, we determined Radii of Gyration (R(g)) by small-angle X-ray scattering (SAXS) and found that the aglycosylated Fc displays a larger R(g) than glycosylated Fc, suggesting a more open C(H)2 orientation under these conditions. Moreover, the R(g) of aglycosylated Fc was reduced by mutations at the C(H)2-C(H)3 interface (E382V/M428I), which confer highly selective binding to FcγRI and novel biological activities.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22747430      PMCID: PMC3448853          DOI: 10.1021/cb300130k

Source DB:  PubMed          Journal:  ACS Chem Biol        ISSN: 1554-8929            Impact factor:   5.100


  43 in total

1.  Crystal structure of Fcγ receptor I and its implication in high affinity γ-immunoglobulin binding.

Authors:  Jinghua Lu; Jeff L Ellsworth; Nels Hamacher; Si Won Oak; Peter D Sun
Journal:  J Biol Chem       Date:  2011-09-29       Impact factor: 5.157

2.  Enhanced natural killer cell binding and activation by low-fucose IgG1 antibody results in potent antibody-dependent cellular cytotoxicity induction at lower antigen density.

Authors:  Rinpei Niwa; Mikiko Sakurada; Yukari Kobayashi; Aya Uehara; Kouji Matsushima; Ryuzo Ueda; Kazuyasu Nakamura; Kenya Shitara
Journal:  Clin Cancer Res       Date:  2005-03-15       Impact factor: 12.531

3.  Aglycosylated immunoglobulin G1 variants productively engage activating Fc receptors.

Authors:  Stephen L Sazinsky; René G Ott; Nathaniel W Silver; Bruce Tidor; Jeffrey V Ravetch; K Dane Wittrup
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-12       Impact factor: 11.205

4.  Conformational changes of three periplasmic receptors for bacterial chemotaxis and transport: the maltose-, glucose/galactose- and ribose-binding proteins.

Authors:  B H Shilton; M M Flocco; M Nilsson; S L Mowbray
Journal:  J Mol Biol       Date:  1996-11-29       Impact factor: 5.469

5.  Expression of full-length immunoglobulins in Escherichia coli: rapid and efficient production of aglycosylated antibodies.

Authors:  Laura C Simmons; Dorothea Reilly; Laura Klimowski; T Shantha Raju; Gloria Meng; Paul Sims; Kyu Hong; Robert L Shields; Lisa A Damico; Patricia Rancatore; Daniel G Yansura
Journal:  J Immunol Methods       Date:  2002-05-01       Impact factor: 2.303

6.  Role of oligosaccharide residues of IgG1-Fc in Fc gamma RIIb binding.

Authors:  Y Mimura; P Sondermann; R Ghirlando; J Lund; S P Young; M Goodall; R Jefferis
Journal:  J Biol Chem       Date:  2001-09-20       Impact factor: 5.157

7.  Studies of aglycosylated chimeric mouse-human IgG. Role of carbohydrate in the structure and effector functions mediated by the human IgG constant region.

Authors:  M H Tao; S L Morrison
Journal:  J Immunol       Date:  1989-10-15       Impact factor: 5.422

Review 8.  Recognition of immunoglobulins by Fcgamma receptors.

Authors:  Sergei Radaev; Peter Sun
Journal:  Mol Immunol       Date:  2002-05       Impact factor: 4.407

9.  Aglycosylated antibodies and the methods of making and using them: WO2008030564.

Authors:  Roy Jefferis
Journal:  Expert Opin Ther Pat       Date:  2009-01       Impact factor: 6.674

10.  Structural comparison of fucosylated and nonfucosylated Fc fragments of human immunoglobulin G1.

Authors:  Shigeki Matsumiya; Yoshiki Yamaguchi; Jun-ichi Saito; Mayumi Nagano; Hiroaki Sasakawa; Shizuo Otaki; Mitsuo Satoh; Kenya Shitara; Koichi Kato
Journal:  J Mol Biol       Date:  2007-02-22       Impact factor: 5.469

View more
  59 in total

Review 1.  The Role and Function of Fcγ Receptors on Myeloid Cells.

Authors:  Stylianos Bournazos; Taia T Wang; Jeffrey V Ravetch
Journal:  Microbiol Spectr       Date:  2016-12

2.  Conformational Plasticity of the Immunoglobulin Fc Domain in Solution.

Authors:  Soumya G Remesh; Anthony A Armstrong; Andrew D Mahan; Jinquan Luo; Michal Hammel
Journal:  Structure       Date:  2018-05-03       Impact factor: 5.006

3.  Reply to Crispin et al.: Molecular model that accounts for the biological and physical properties of sialylated Fc.

Authors:  Peter Sondermann; Andrew Pincetic; Jad Maamary; Katja Lammens; Jeffrey V Ravetch
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-17       Impact factor: 11.205

4.  Therapeutic potential of deglycosylated antibodies.

Authors:  Max Crispin
Journal:  Proc Natl Acad Sci U S A       Date:  2013-06-07       Impact factor: 11.205

5.  High-resolution structures of the IgM Fc domains reveal principles of its hexamer formation.

Authors:  Roger Müller; Melissa A Gräwert; Thomas Kern; Tobias Madl; Jirka Peschek; Michael Sattler; Michael Groll; Johannes Buchner
Journal:  Proc Natl Acad Sci U S A       Date:  2013-06-03       Impact factor: 11.205

6.  Fc Engineering of Human IgG1 for Altered Binding to the Neonatal Fc Receptor Affects Fc Effector Functions.

Authors:  Algirdas Grevys; Malin Bern; Stian Foss; Diane Bryant Bratlie; Anders Moen; Kristin Støen Gunnarsen; Audun Aase; Terje Einar Michaelsen; Inger Sandlie; Jan Terje Andersen
Journal:  J Immunol       Date:  2015-04-22       Impact factor: 5.422

7.  Advanced analyses of kinetic stabilities of iggs modified by mutations and glycosylation.

Authors:  Erik Sedlák; Jonas V Schaefer; Jozef Marek; Peter Gimeson; Andreas Plückthun
Journal:  Protein Sci       Date:  2015-06-11       Impact factor: 6.725

Review 8.  Considerations for the Design of Antibody-Based Therapeutics.

Authors:  Dennis R Goulet; William M Atkins
Journal:  J Pharm Sci       Date:  2019-06-04       Impact factor: 3.534

9.  High-throughput biophysical analysis and data visualization of conformational stability of an IgG1 monoclonal antibody after deglycosylation.

Authors:  Mohammad A Alsenaidy; Jae Hyun Kim; Ranajoy Majumdar; David D Weis; Sangeeta B Joshi; Thomas J Tolbert; C Russell Middaugh; David B Volkin
Journal:  J Pharm Sci       Date:  2013-09-24       Impact factor: 3.534

10.  Immunoglobulin G1 Fc domain motions: implications for Fc engineering.

Authors:  Martin Frank; Ross C Walker; William N Lanzilotta; James H Prestegard; Adam W Barb
Journal:  J Mol Biol       Date:  2014-02-09       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.